Search clinical trials for: Aripiprazole with Clozapine

Total 17757 results

Alkermes, Inc.

Completed

A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia

Schizophrenia

United States
Yale University

Recruiting

Potential Impact of Menthol Ban in Cigarettes and E-cigarettes

Tobacco Smoking

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Bipolar Disorder

United States, South Africa, Brazil, Russian Federation, France, Czechia, Croatia, India, Bulgaria
University of Calgary

Completed

DBS for Treatment Resistant Depression (CRIO-DBS)

Depressive Disorder, Treatment-Resistant

Canada
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Agitated Patients With Bipolar Disorder

Bipolar I Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Covance

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

Spain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Schizophrenia

United States
University of Miami
Alkermes, Inc.

Recruiting

C-Cog in Early Course Schizophrenia Study

Schizophrenia

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression; Pfizer

Completed

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE- EU)

Schizophrenia

Belgium, Bulgaria, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole in Adolescents With Schizophrenia (APEX 239)

Schizophrenia

United States, Puerto Rico
Inje University

Unknown

The New Strategy for Pharmacological Treatment in People With Schizophrenia

Schizophrenia

Korea, Republic of
University of Witten/Herdecke

Terminated

Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain (LOX2015PILOT)

Neuropathic Pain

Germany
Bjorn H. Ebdrup
University of Copenhagen; Lundbeck Foundation; Danish Research Centre for Magnetic...

Recruiting

Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis (AMEND)

Psychosis | Negative Symptoms With Primary Psychotic Disorder

Denmark
Central Hospital, Nancy, France

Completed

Target Attainment of TDM-guided Infusion of Piperacillin/Tazobactam and Cefepim in Critically Ill Patients (DOSATB)

Sepsis | Critical Illness | Septic Shock | Antibiotic Toxicity

France
Xidian University

Unknown

Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study

Schizophrenia, Bipolar Disorder
Seoul National University Hospital
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Completed

Loxapine and Weaning From Ventilator

Psychomotor Agitation | Respiratory Insufficiency

France
Alkermes, Inc.

Completed

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia

Schizophrenia

United States
Janssen Research & Development, LLC

Completed

An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

Hepatitis C, Chronic

United States
Peter J. Ruane, M.D.
Janssen Scientific Affairs, LLC

Completed

Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

Tourette Syndrome

China
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine Pulmonary Safety in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States
Assistance Publique - Hôpitaux de Paris

Completed

Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning (Sevralox)

Restlessness

France
University of Texas Southwestern Medical Center
National Institute of Mental Health (NIMH); Beth Israel Deaconess Medical Center and other collaborators

Recruiting

CLOZAPINE Response in Biotype-1

Schizophrenia | Schizoaffective Disorder | Bipolar 1 Disorder

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

BiPolar

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine Pulmonary Safety in Healthy Volunteers

Healthy

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

Women's Initiative Supporting Health Increasing Healthcare Access (WISH)

Substance-Related Disorders

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine in Migraine (in Clinic)

Migraine

United States
Lee's Pharmaceutical Limited

Unknown

A Study of Staccato Loxapine (ADASUVE®) for Inhalation

Schizophrenia | Psychomotor Agitation | Bipolar Disorder
Janssen Research & Development, LLC

Completed

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection (ACCORDION-1)

Hepatitis C Virus

United States, Canada
Eunice Kennedy Shriver National Institute of Child...

Completed

Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay

Mental Retardation | Developmental Delay Disorder

United States
Ferrer Internacional S.A.

Completed

Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting

Agitation

Spain
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg

Healthy

United States
National Institute of Mental Health (NIMH)

Completed

Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents

Bipolar Disorder

United States
Lawson Health Research Institute
Bristol-Myers Squibb

Completed

Aripiprazole and Resistant Postpartum Depression

Postpartum Depression

Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Alzheimer Disease

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Alzheimer Disease

United States
National Institute on Drug Abuse (NIDA)

Completed

Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients

Opioid-Related Disorders | Cocaine-Related Disorders | Cocaine Dependence

United States
Mental Health Services in the Capital Region, Denmark

Recruiting

Biomarkers in Clozapine-responding Schizophrenia (BiCS)

Schizophrenia | Psychosis

Denmark
University of Maryland, Baltimore

Completed

Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) (BEN)

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole in Patients With Acute Mania

Bipolar Disorder

United States
Centre for Addiction and Mental Health

Recruiting

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
Novartis

Completed

A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia

Schizophrenia
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine Pulmonary Safety in Patients With Asthma

Asthma

United States
Medical University of Gdansk

Enrolling by invitation

Observation of Clozapine Treatment Safety in Bipolar Disorder. (CloGD)

Bipolar Disorder

Poland
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study

Schizophrenia

Canada
Bristol-Myers Squibb

Completed

Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

Active Psoriatic Arthritis

Spain, United States, Hungary, Germany, Poland, United Kingdom, Russian Federation, Italy, Czechia
Tirat Carmel Mental Health Center
Technion, Israel Institute of Technology; HaEmek Medical Center, Israel; Beersheva... and other collaborators

Completed

Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients

Schizophrenia

Israel
Novartis

Completed

A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia

Schizophrenia

Japan

Search clinical trials for: Aripiprazole with Clozapine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations